|
ABT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.094500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.364770E-01 |
| Normal-vs-Stage2 |
2.201900E-02 |
| Normal-vs-Stage3 |
1.826440E-02 |
| Normal-vs-Stage4 |
3.344500E-03 |
| Stage1-vs-Stage2 |
1.634430E-01 |
| Stage1-vs-Stage3 |
1.797400E-01 |
| Stage1-vs-Stage4 |
5.879800E-02 |
| Stage2-vs-Stage3 |
7.060200E-01 |
| Stage2-vs-Stage4 |
7.201800E-01 |
| Stage3-vs-Stage4 |
4.159800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.321900E-02 |
| Normal-vs-AfricanAmerican |
7.985800E-02 |
| Normal-vs-Asian |
8.693000E-01 |
| Caucasian-vs-AfricanAmerican |
6.883800E-01 |
| Caucasian-vs-Asian |
6.234100E-02 |
| AfricanAmerican-vs-Asian |
1.075200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.385700E-02 |
| Normal-vs-Female |
3.490100E-02 |
| Male-vs-Female |
5.499000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.646620E-01 |
| Normal-vs-Age(41-60Yrs) |
4.189900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.555900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.413200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.685800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.780000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.856200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.601250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.731770E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.398000E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.769800E-02 |
| Classical-VS-Follicular |
3.117300E-03 |
| Classical-VS-Other |
2.542200E-01 |
| Classical-VS-Normal |
3.229200E-01 |
| Tall-VS-Follicular |
6.454200E-01 |
| Tall-VS-Other |
8.851400E-01 |
| Tall-VS-Normal |
1.769910E-02 |
| Follicular-VS-Other |
9.277800E-01 |
| Follicular-VS-Normal |
1.518300E-03 |
| Other-VS-Normal |
1.172600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.847830E-02 |
| Normal-vs-N1 |
8.655200E-03 |
| N0-vs-N1 |
3.594400E-01 |
|
|
